MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Bare-Metal Stents for Primary PCI
Challenging the myths with evidence.
By Ander Regueiro, MD, and Manel Sabaté,, MD, PhD
Percutaneous Mitral Valve Replacement
An overview of the transcatheter valve replacement therapies for treating mitral regurgitation.
By Ander Regueiro, MD, and Josep Rodé,s-Cabau, MD
OpSens Commences SAFE-TAVI Study for European Approval of SavvyWire
October 26, 2022—OpSens Inc. announced the successful completion of the first cases in the SAFE-TAVI clinical study in Europe, which is evaluating the company’s SavvyWire left ventricular rapid pacing in transcatheter aortic valve replacement (TAVR) procedures in Europe.
OpSens SavvyWire Evaluated in European SAFE-TAVI Study
October 23, 2023—OpSens Inc. announced the publication of results from SAFE-TAVI, a clinical study on the safety and efficacy of left ventricular (LV) rapid pacing using the company’s SavvyWire in transcatheter aortic valve replacement (TAVR) procedures in Europe.
Options in PCI and AMI
By Ted E. Feldman, MD, FESC, FACC, FSCAI
Mitral Technology & Lesion Assessment
By Ted E. Feldman, MD, MSCAI, FACC, FESC
Status of Transcatheter Mitral Valve Replacement
An emerging frontier with unique anatomic, technical, and clinical challenges.
By Nishtha Sodhi, MD, and Alan Zajarias, MD
